Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Chem Biol Drug Des ; 102(1): 201-216, 2023 07.
Artículo en Inglés | MEDLINE | ID: mdl-36929632

RESUMEN

Nowadays, there is a lot of public and scientific interest in using phytochemicals to treat human ailments. Existing cancer medicines still run across obstacles, despite significant advancements in the field. For instance, chemotherapy may result in severe adverse effects, increased drug resistance, and treatment failure. Natural substances that are phytochemically derived provide innovative approaches as potent therapeutic molecules for the treatment of cancer. Bioactive natural compounds may enhance chemotherapy for cancer by increasing the sensitivity of cancer cells to medicines. Propolis has been found to interfere with the viability of cancer cells, among other phytochemicals. Of all the components that make up propolis, caffeic acid phenethyl ester (CAPE) (a flavonoid) has been the subject of the most research. It demonstrates a broad spectrum of therapeutic uses, including antitumor, antimicrobial, antiviral, anti-inflammatory, immunomodulatory, hepatoprotective, neuroprotective, and cardioprotective effects. Studies conducted in vitro and in vivo have demonstrated that CAPE specifically targets genes involved in cell death, cell cycle regulation, angiogenesis, and metastasis. By altering specific signaling cascades, such as the NF-κB signaling pathway, CAPE can limit the proliferation of human cancer cells. This review highlights the research findings demonstrating the anticancer potential of CAPE with a focus on multitargeted molecular and biological implications in various cancer models.


Asunto(s)
Antineoplásicos , Neoplasias , Alcohol Feniletílico , Própolis , Humanos , Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Antineoplásicos/química , Própolis/farmacología , Própolis/uso terapéutico , Própolis/química , Apoptosis , Alcohol Feniletílico/farmacología , Alcohol Feniletílico/uso terapéutico , Alcohol Feniletílico/química , Ácidos Cafeicos/farmacología , Ácidos Cafeicos/uso terapéutico , Ácidos Cafeicos/química , Neoplasias/tratamiento farmacológico
2.
Mini Rev Med Chem ; 22(9): 1289-1304, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-34598663

RESUMEN

Cancer is one of the deadliest diseases in many developed and developing countries. Continuous efforts are required for designing better therapeutic agents for the treatment of cancer with more efficacy, selectivity, and less toxicity. The fused heterocyclic ring system has been identified by several researchers as a privileged structure that can be used as the basis for drug discovery in medicinal chemistry. The hetero-aromatic bicyclic ring system acts as a pharmacophore in a wide range of drugs with therapeutic potential. According to studies in the literature, various substituted benzimidazoles have distinct pharmacological profiles with multi-targeting ability, making them an important anchor for the production of novel therapeutic agents against complex cancers, including breast cancer, skin cancer, and blood cancer. In this article, we have discussed various synthetic methods for the synthesis of anti-cancer benzimidazoles and their derivatives in different solvent conditions, substrates, and various catalysts, mainly those which are eco-friendly and economical. We also focused on various derivatives those are under clinical trials containing benzimidazole moiety.


Asunto(s)
Antineoplásicos , Neoplasias , Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Bencimidazoles/química , Bencimidazoles/farmacología , Bencimidazoles/uso terapéutico , Química Farmacéutica , Descubrimiento de Drogas , Humanos , Neoplasias/tratamiento farmacológico , Relación Estructura-Actividad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA